Business Context and Reporting Period
Company: Coca-Cola Europacific Partners Plc (CCEP)
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Date: November 15, 2024
Subject: Announcement of the approval by the Financial Conduct Authority (FCA) to transfer the listing category of CCEP's ordinary shares from the "Equity Shares (Transition)" category to the "Equity Shares (Commercial Companies)" category of the Official List. The transfer became effective at 8:00 a.m. GMT on November 15, 2024.
Key Financial Metrics
This filing is a regulatory announcement regarding listing status and does not contain financial performance data.
- Revenue, Profit, Cash Flow, Margins: Not provided in this filing.
- Debt and Liquidity: Not provided in this filing.
- Trading Volume Requirement: To qualify for future FTSE UK Index Series admission, the company must meet a Median Liquidity Test requiring a minimum of 0.025% of traded free float to be traded on UK equity venues against the sterling quote. This is currently equivalent to approximately 51,000 shares (c. £3.1 million) per day.
Material Changes
Listing Category Transfer: The primary material change is the successful migration of the company's listing status to the "Equity Shares (Commercial Companies)" category. This is a prerequisite for potential inclusion in the FTSE UK Index Series.
Index Eligibility Timeline: Subject to meeting the liquidity test, the earliest potential admission to the FTSE UK Index Series would be ahead of the quarterly rebalancing review in March 2025. The liquidity test must be satisfied in each month from November 2024 through February 2025.
Guidance, Outlook, and Risks
Outlook: The company anticipates eligibility for the FTSE UK Index Series in due course, contingent upon meeting the liquidity requirements and obtaining FTSE approval.
Risks and Contingencies:
- Liquidity Test Uncertainty: There is no certainty that the required trading volume (Median Liquidity Test) will be met.
- Forward-Looking Statements: The filing includes standard disclaimers that actual results may differ materially from projections due to risks affecting financial condition, operations, growth, capital ratios, and regulatory compliance.
- Share Price Impact: Risks identified may adversely affect the company's share price.
Investor Verification Checklist
- Verify the daily trading volume of CCEP shares on UK equity venues (London Stock Exchange, CBOE CXE, CBOE BXE, CBOE OTC) to assess progress toward the 51,000 shares/day threshold.
- Monitor announcements regarding the outcome of the monthly Liquidity Test between November 2024 and February 2025.
- Confirm the date of the next FTSE Russell quarterly rebalancing review (expected March 2025) for potential index inclusion.
- Review the company's latest Form 20-F or annual report for actual financial performance metrics, as this 6-K filing contains none.